https://orcid.org/0000-0002-0181-3076
References
- Bouillon R, Manousaki D, Rosen C, et al. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. 2022;18(2):96–110. doi:10.1038/s41574-021-00593-z.
- Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2020;106(1):14–29. doi:10.1007/s00223-019-00559-4.
- Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–78. doi:10.1016/j.annepidem.2007.12.001.
- National Kidney Foundation. National kidney foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1–S201.
- Pilz S, Zittermann A, Trummer C, et al. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect. 2019;8(2):R27–R43. doi:10.1530/EC-18-0432.
- Binkley N, Dawson-Hughes B, Durazo-Arvizu R, et al. Vitamin D measurement standardization: the way out of the chaos. J Steroid Biochem Mol Biol. 2017;173:117–121. doi:10.1016/j.jsbmb.2016.12.002.
- Binkley N, Krueger D, Cowgill CS, et al. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. J Clin Endocrinol Metab. 2004;89(7):3152–3157. doi:10.1210/jc.2003-031979.
- Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D. Br. Br J Clin Pharmacol. 2018;84(10):2194–2207. doi:10.1111/bcp.13652.
- Binkley N, Sempos CT. Standardizing vitamin D assays: the way forward. J Bone Miner Res. 2014;29(8):1709–1714. doi:10.1002/jbmr.2252.
- Stöckl D, Sluss PM, Thienpont LM. Specifications for trueness and precision of a reference measurement system for serum/plasma 25-hydroxyvitamin D analysis. Clin Chim Acta. 2009;408(1–2):8–13. doi:10.1016/j.cca.2009.06.027.
- Wise SA, Camara JE, Sempos CT, et al. Vitamin D standardization program (VDSP) intralaboratory study for the assessment of 25-hydroxyvitamin D assay variability and bias. J Steroid Biochem Mol Biol. 2021;212:105917. doi:10.1016/j.jsbmb.2021.105917.
- Shander A, Javidroozi M, Lobel G. Patient blood management in the intensive care unit. Transfus Med Rev. 2017;31(4):264–271. doi:10.1016/j.tmrv.2017.07.007.
- Wang Q, Pu G, Tang G, et al. Mechanism of heparin interference in detection of LIAISON® rubella IgM. Clin Chim Acta. 2020;511:7–13. doi:10.1016/j.cca.2020.09.021.
- Cavalier E, Fraser CG, Bhattoa HP, et al. Analytical performance specifications for 25-Hydroxyvitamin D examinations. Nutrients. 2021;13(2):431. doi:10.3390/nu13020431.